ECSP077283A - Agente antiprotozoario - Google Patents
Agente antiprotozoarioInfo
- Publication number
- ECSP077283A ECSP077283A EC2007007283A ECSP077283A ECSP077283A EC SP077283 A ECSP077283 A EC SP077283A EC 2007007283 A EC2007007283 A EC 2007007283A EC SP077283 A ECSP077283 A EC SP077283A EC SP077283 A ECSP077283 A EC SP077283A
- Authority
- EC
- Ecuador
- Prior art keywords
- agent
- antiprotozoary
- present
- antiprotozoal
- antiprotozoal agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención provee un agente antiprotozoarios, el cual, es preferido, particularmente, como un agente antileishmaniático. La presente invención está, específicamente, direccionado a un agente antiprotozoarios que comprende, como un ingrediente activo, un compuesto de Fórmula (I): donde R es -H ó acilo, una sal del mismo o solvato del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004223485 | 2004-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP077283A true ECSP077283A (es) | 2007-03-29 |
Family
ID=35786144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2007007283A ECSP077283A (es) | 2004-07-30 | 2007-02-28 | Agente antiprotozoario |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080254136A1 (es) |
EP (1) | EP1779892A4 (es) |
JP (1) | JP4899002B2 (es) |
CN (1) | CN101048154A (es) |
BR (1) | BRPI0513951A (es) |
EC (1) | ECSP077283A (es) |
IL (1) | IL180956A0 (es) |
WO (1) | WO2006011394A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2101749A4 (en) * | 2006-12-12 | 2010-04-21 | Jin Do County | PHARMACEUTICAL COMPOSITION COMPRISING SHIKONIN DERIVATIVES FROM LITHOSPERMUM ERYTHRORHIZON FOR THE TREATMENT OR PREVENTION OF SWEET DIABETES, AND THE USE THEREOF |
EP2557076B1 (en) | 2010-10-19 | 2013-10-09 | Aoyama Gakuin Educational Foundation | Anti-leishmania compound and anti-leishmania drug |
JP4762381B1 (ja) | 2010-10-19 | 2011-08-31 | 学校法人青山学院 | 抗リーシュマニア化合物及び抗リーシュマニア薬 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5653529B2 (es) * | 1972-09-18 | 1981-12-19 | ||
GB8310140D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Antiprotozoal agents |
GB8310141D0 (en) * | 1983-04-14 | 1983-05-18 | Wellcome Found | Naphthoquinone derivatives |
GB8819477D0 (en) * | 1988-08-16 | 1988-09-21 | Wellcome Found | Medicaments |
HU208624B (en) * | 1988-08-16 | 1993-12-28 | Wellcome Found | Process for producing pharmaceutical compositions containing naphtoquinone derivatives effective against pneumocystis infections |
EP0395294A3 (en) * | 1989-04-25 | 1991-05-22 | Takeda Chemical Industries, Ltd. | Control of protozoal disease |
JPH10212230A (ja) * | 1997-01-29 | 1998-08-11 | Kureha Chem Ind Co Ltd | Hsp60ファミリーに属するタンパク質のジヒドロキシナフトキノン化合物含有合成抑制剤 |
JP2002212065A (ja) * | 2001-01-23 | 2002-07-31 | Univ Showa | チロシンキナーゼ阻害剤及び医薬組成物 |
JP2004075613A (ja) * | 2002-08-19 | 2004-03-11 | Club Cosmetics Co Ltd | 保湿剤及び皮膚外用剤並びにシコン抽出物の使用方法 |
JP2004091386A (ja) * | 2002-08-30 | 2004-03-25 | Club Cosmetics Co Ltd | 外用皮膚潰瘍治療剤及び皮膚潰瘍治療用キット並びにシコン抽出物の使用方法 |
EP1417886A1 (en) * | 2002-11-06 | 2004-05-12 | Ciba SC Holding AG | Substituted phenols as useful repellents for insects |
-
2005
- 2005-07-20 BR BRPI0513951-1A patent/BRPI0513951A/pt not_active IP Right Cessation
- 2005-07-20 WO PCT/JP2005/013268 patent/WO2006011394A1/ja active Application Filing
- 2005-07-20 JP JP2006529230A patent/JP4899002B2/ja active Active
- 2005-07-20 EP EP05766412A patent/EP1779892A4/en not_active Withdrawn
- 2005-07-20 CN CNA2005800326679A patent/CN101048154A/zh active Pending
- 2005-07-20 US US11/632,959 patent/US20080254136A1/en not_active Abandoned
-
2007
- 2007-01-25 IL IL180956A patent/IL180956A0/en unknown
- 2007-02-28 EC EC2007007283A patent/ECSP077283A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN101048154A (zh) | 2007-10-03 |
EP1779892A4 (en) | 2010-05-19 |
JPWO2006011394A1 (ja) | 2008-05-01 |
US20080254136A1 (en) | 2008-10-16 |
WO2006011394A1 (ja) | 2006-02-02 |
IL180956A0 (en) | 2007-07-04 |
BRPI0513951A (pt) | 2008-05-20 |
EP1779892A1 (en) | 2007-05-02 |
JP4899002B2 (ja) | 2012-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010526A (es) | Compuesto heterociclico | |
CR9753A (es) | Agente terapeutico para diabetes | |
CY1112722T1 (el) | Μυκητοκτονες συνθεσεις | |
UY32730A (es) | Inhibidores de cyp17 | |
CR10748A (es) | Compuesto de indol | |
BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
CR20110492A (es) | Compuestos tetracíclicos | |
CU20120071A7 (es) | DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA | |
CY1115902T1 (el) | Συνδυαστικη θεραπεια καρκινου με ανασταλτικες ενωσεις hps90 | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
SV2006002187A (es) | Indazoles utiles para tratamientos de enfermedades cardiovasculares ref.wyth0089-504(am101590) | |
GEP20146003B (en) | Benzothiazole derivatives as anticancer agents | |
CO6531452A2 (es) | Piperidinas sustituidas que aumentan la actividad de p53 y sus usos | |
EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
UY32045A (es) | Compuesto amida | |
UY30451A1 (es) | 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen. | |
HN2010000330A (es) | DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION | |
NI202000031A (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3 | |
GT200700057A (es) | Nuevos derivados de piridazina | |
CO6430466A2 (es) | Derivados de pirazolopirimidina triciclicos | |
CO6382105A2 (es) | Agente preventivo/terapéutico contra el cancer | |
BRPI0713743C1 (pt) | composto, e, composição farmacêutica | |
ECSP077283A (es) | Agente antiprotozoario | |
ECSP088374A (es) | Formulacion de aerosol para inhalacion | |
MY146775A (en) | Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |